Eczacibasi Ilac to market German MediGenes Veregen in Turkey.

By bne IntelliNews January 24, 2012
German biotech company MediGene AG informed in a written statement that it signed an exclusive license and supply agreement with local Eczacibasi Groups EIP Eczacibasi Ilac Pazarlama for the supply and commercialization of its Veregen brand ointment in Turkey. MediGene has not provided any financial information regarding the agreement, but it informed that EIP Eczacibasi will be responsible of required approvals from the related local authorities. Eczacibasi Group currently operates 39 companies with a workforce of 10,100 employees and it posted a turnover of EUR 2.1bn last year.

Related Articles

PKK leader Ocalan calls for ceasefire and withdrawal of militants from Turkey.

The jailed leader of the PKK, Abdullah Ocalan, called for a ceasefire on Thursday, ordering armed PKK militants to withdraw from Turkey. Hundreds of thousands of people gathered in the city of ... more

Syrian government says Turkey responsible for chemical attack.

The Syrian government said the rebel groups foreign supporters, Turkey and Qatar, were responsible for a chemical attack in Aleppo. The countries that back and support the rebels, including ... more

Erdogans comments on Zionism clouds US secretary of states Turkey visit.

US secretary of state John Kerry was in Ankara on Friday for talks with the Turkish leaders, including PM Recep Tayyip Erdogan and President Abdullah Gul, focused on the crisis in Syria, ... more

Notice: Undefined index: subject_id in /var/www/html/application/controllers/IndexController.php on line 335
Dismiss